Clinical trial
Effects of L-arginine Supplementation in Adults With Moderate to Severe Asthma
NCT00280683 · University of California, Davis, Other · Completed
Key facts
| NCT number | NCT00280683 |
|---|---|
| Title | Effects of L-arginine Supplementation in Adults With Moderate to Severe Asthma |
| Official title | Phase 2 Study: GCRC: Effects of L-arginine Supplementation on Exhaled Nitric Oxide and Clinical Exacerbations in Adults With Moderate to Severe Asthma |
| Lead sponsor | University of California, Davis, Other |
| Collaborators | National Institutes of Health (NIH) NIH National Center for Research Resources (NCRR) |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Asthma |
| Intervention type | Drug |
| Interventions | L-arginine, Placebo |
| Enrollment | 20 |
| Start date | Dec 1, 2004 |
| Primary completion | Nov 1, 2008 |
| Completion | Dec 1, 2008 |
| First posted | Jan 23, 2006 |
| Last update posted | May 30, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: